• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Compliance in adjuvant chemotherapy].

作者信息

Michel U, Schwarz R, Kaufmann M

出版信息

Rehabilitation (Stuttg). 1986 Feb;25(1):17-23.

PMID:3754346
Abstract

The study presented deals with the issue of therapy compliance on the example of female patients with breast carcinoma, who had received adjuvant chemotherapy. Catamnestic results are reported for 44 patients who had answered a complaints questionnaire and participated, additionally, in unstructured interviewing on the problems and strain experienced during and following therapy. The study group consisted of 10 women who had dropped out of treatment, and 34 women who had followed the treatment as scheduled. The physical and emotional strain found are reported, and discussed from the perspective of therapy compliance. Of particular interest in this context is the doctor-patient-relationship, i.e. the question of how the patients' subjective considerations and medical cost-benefit calculations could be heeded in as open and trustful an exchange between doctor and patient as possible.

摘要

相似文献

1
[Compliance in adjuvant chemotherapy].
Rehabilitation (Stuttg). 1986 Feb;25(1):17-23.
2
[A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].一项随机对照研究,在辅助治疗背景下,比较尿嘧啶替加氟(UFT)+他莫昔芬(UFT + TAM疗法)与环磷酰胺+阿霉素+ 5-氟尿嘧啶(CAF疗法)用于治疗有四个或更多受累淋巴结的I、II或IIIa期乳腺癌女性患者的疗效。
Gan To Kagaku Ryoho. 2006 Oct;33(10):1423-9.
3
Polychemotherapy for early breast cancer: results from the international adjuvant breast cancer chemotherapy randomized trial.早期乳腺癌的多药化疗:国际辅助性乳腺癌化疗随机试验的结果
J Natl Cancer Inst. 2007 Apr 4;99(7):506-15. doi: 10.1093/jnci/djk108.
4
[Adriamycin/cyclophosphamide: current standard in adjuvant therapy for breast carcinoma?].[阿霉素/环磷酰胺:乳腺癌辅助治疗的当前标准?]
Schweiz Med Wochenschr. 1994 Oct 29;124(43):1879-81.
5
Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897.接受西南肿瘤协作组S8897方案治疗的乳腺癌幸存者辅助化疗的晚期心脏影响
J Clin Oncol. 2008 Mar 10;26(8):1223-30. doi: 10.1200/JCO.2007.11.8877. Epub 2008 Jan 28.
6
Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.环磷酰胺、甲氨蝶呤、5-氟尿嘧啶、长春新碱和泼尼松辅助化疗与单药左旋苯丙氨酸氮芥治疗可手术乳腺癌且腋窝淋巴结阳性患者的比较:西南肿瘤协作组20年研究结果
Cancer. 2003 Jan 1;97(1):21-9. doi: 10.1002/cncr.10982.
7
Clinical trials referral resource. Adjuvant therapy of breast cancer.
Oncology (Williston Park). 1989 Jun;3(6):70-1, 74-5, 78.
8
Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.血管内皮生长因子和胸苷磷酸化酶在接受辅助化疗或激素治疗的淋巴结阳性乳腺癌患者中的临床相关性。
Cancer J Sci Am. 1999 Mar-Apr;5(2):101-11.
9
Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.高危乳腺癌患者中传统辅助化疗与单周期、自体移植支持的大剂量晚期强化化疗的随机试验
J Natl Cancer Inst. 2004 Jul 21;96(14):1076-83. doi: 10.1093/jnci/djh188.
10
[Adriamycin/cyclophosphamide: current standard in the adjuvant therapy of breast carcinoma? Or: how should one really put this question?].[阿霉素/环磷酰胺:乳腺癌辅助治疗的当前标准?或者:应该如何真正提出这个问题?]
Schweiz Med Wochenschr. 1994 Oct 29;124(43):1882-4.